Ardelyx

Patent cliffs & loss of exclusivity

A biopharmaceutical company developing oral therapeutics for the treatment of mineral metabolism and metabolic disorders

Company

AngelList URLhttps://angel.co/ardelyx
CAGE Code59BW4
Legal NameArdelyx, Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/ardelyx
Email format{f}{last}
Facebook URLhttps://www.facebook.com/Ardelyx
Full Address34175 Ardenwood Blvd, Fremont, CA 94555, US

4 upcoming patent cliffs

DrugIngredientTypeCliff
  1. IBSRELATENAPANOR HYDROCHLORIDESmall mol.Nov 2042
  2. XPHOZAHTENAPANOR HYDROCHLORIDESmall mol.Nov 2042
  3. XPHOZAHTENAPANOR HYDROCHLORIDESmall mol.Nov 2042
  4. XPHOZAHTENAPANOR HYDROCHLORIDESmall mol.Nov 2042

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.